First Header Logo Second Header Logo

Search Results (5)

More Search Options
MatchTypeWhy
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.Academic Article Why?
Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology.Academic Article Why?
The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia.Academic Article Why?
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: The Big Step Forward in Lipid Control.Academic Article Why?
Proprotein Convertase 1Concept Why?
Proprotein Convertase 2Concept Why?
Proprotein Convertase 5Concept Why?
Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population.Academic Article Why?
Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.Academic Article Why?
Shapiro, MichaelPerson Why?
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Academic Article Why?
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Academic Article Why?
Application of PCSK9 Inhibitors in Practice.Academic Article Why?
Application of PCSK9 Inhibitors in Practice: Challenges and Opportunities.Academic Article Why?
Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • Proprotein Convertase 2
Filter by Type
_
Click "Why?" to see why an item matched the search.